Free Trial

Clarivate (CLVT) Competitors

Clarivate logo
$4.38 +0.16 (+3.67%)
Closing price 07/22/2025 03:58 PM Eastern
Extended Trading
$4.43 +0.06 (+1.37%)
As of 07/22/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLVT vs. RTO, BILI, MEDP, FOUR, HQY, MARA, LYFT, ETSY, WPP, and AMTM

Should you be buying Clarivate stock or one of its competitors? The main competitors of Clarivate include Rentokil Initial (RTO), Bilibili (BILI), Medpace (MEDP), Shift4 Payments (FOUR), HealthEquity (HQY), Marathon Digital (MARA), Lyft (LYFT), Etsy (ETSY), WPP (WPP), and Amentum (AMTM). These companies are all part of the "business services" industry.

Clarivate vs. Its Competitors

Clarivate (NYSE:CLVT) and Rentokil Initial (NYSE:RTO) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

85.7% of Clarivate shares are owned by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are owned by institutional investors. 23.2% of Clarivate shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Rentokil Initial has a net margin of 0.00% compared to Clarivate's net margin of -26.32%. Clarivate's return on equity of 8.75% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
Clarivate-26.32% 8.75% 3.96%
Rentokil Initial N/A N/A N/A

Clarivate presently has a consensus target price of $4.83, indicating a potential upside of 10.48%. Given Clarivate's higher probable upside, analysts clearly believe Clarivate is more favorable than Rentokil Initial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clarivate
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75
Rentokil Initial
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.80

Clarivate has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500.

Rentokil Initial has higher revenue and earnings than Clarivate. Clarivate is trading at a lower price-to-earnings ratio than Rentokil Initial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clarivate$2.56B1.17-$636.70M-$0.97-4.51
Rentokil Initial$6.95B1.80$392.32M$1.5116.37

In the previous week, Clarivate had 10 more articles in the media than Rentokil Initial. MarketBeat recorded 11 mentions for Clarivate and 1 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 0.94 beat Clarivate's score of 0.74 indicating that Rentokil Initial is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clarivate
4 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rentokil Initial
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Rentokil Initial beats Clarivate on 10 of the 17 factors compared between the two stocks.

Get Clarivate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLVT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLVT vs. The Competition

MetricClarivateIT Services IndustryComputer SectorNYSE Exchange
Market Cap$2.88B$16.74B$28.84B$20.75B
Dividend YieldN/A1.52%3.02%3.65%
P/E Ratio-4.5138.0933.9827.65
Price / Sales1.1712.761,755.5854.28
Price / Cash2.5225.0338.1322.19
Price / Book0.615.057.594.65
Net Income-$636.70M$434.10M$781.12M$993.85M
7 Day Performance4.54%3.80%2.17%1.86%
1 Month Performance9.65%7.69%8.53%5.63%
1 Year Performance-34.70%11.89%52,878.52%10.35%

Clarivate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLVT
Clarivate
2.2716 of 5 stars
$4.38
+3.7%
$4.83
+10.5%
-33.6%$2.88B$2.56B-4.5112,000
RTO
Rentokil Initial
2.261 of 5 stars
$23.15
+0.7%
N/A-22.3%$11.69B$5.44B15.3368,485Analyst Forecast
Gap Up
BILI
Bilibili
1.6076 of 5 stars
$22.32
+4.1%
$23.29
+4.3%
+61.2%$9.33B$3.68B-111.598,088
MEDP
Medpace
3.5234 of 5 stars
$320.36
-1.0%
$344.82
+7.6%
+9.3%$9.21B$2.11B24.455,900Trending News
Earnings Report
Gap Up
FOUR
Shift4 Payments
2.7064 of 5 stars
$103.22
+2.3%
$116.10
+12.5%
+55.3%$9.15B$3.33B34.874,000Upcoming Earnings
HQY
HealthEquity
3.2738 of 5 stars
$97.34
+3.0%
$118.55
+21.8%
+29.1%$8.42B$1.20B71.053,120Positive News
MARA
Marathon Digital
2.0794 of 5 stars
$19.21
+0.4%
$20.94
+9.0%
-17.0%$6.76B$656.38M-13.259Upcoming Earnings
Analyst Forecast
High Trading Volume
LYFT
Lyft
4.3992 of 5 stars
$14.92
+0.1%
$16.78
+12.4%
+19.1%$6.24B$5.79B99.472,934Trending News
Analyst Forecast
Options Volume
ETSY
Etsy
3.7122 of 5 stars
$57.71
-0.3%
$49.91
-13.5%
+2.1%$6.02B$2.81B41.222,400Trending News
Upcoming Earnings
Analyst Upgrade
WPP
WPP
2.3165 of 5 stars
$27.74
-0.9%
N/A-40.8%$5.98B$14.74B4.65108,044High Trading Volume
AMTM
Amentum
1.2034 of 5 stars
$24.21
+2.2%
$25.22
+4.2%
N/A$5.89B$11.26B0.0053,000

Related Companies and Tools


This page (NYSE:CLVT) was last updated on 7/23/2025 by MarketBeat.com Staff
From Our Partners